Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Coombes

Showing results (321-330 of 334) with videos related to

Pageof 34
Sort By:
Clinical Proteomics|September 13, 2011
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancerAna M Gonzalez-Angulo, Bryan T Hennessy, Funda Meric-Bernstam, et al.
Blood|April 16, 2010
microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survivalSimona Rossi, Masayoshi Shimizu, Elisa Barbarotto, et al.
Leukemia|January 24, 2014
BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignanciesJ M Bogenberger, S M Kornblau, W E Pierceall, et al.
Journal of the National Cancer Institute|January 17, 2012
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcomeNathan T Ihle, Lauren A Byers, Edward S Kim, et al.
Gynecologic Oncology|April 11, 2012
Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancerSiqing Fu, Bryan T Hennessy, Chaan S Ng, et al.
Cancer Discovery|September 11, 2012
Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1Lauren Averett Byers, Jing Wang, Monique B Nilsson, et al.
Blood|July 12, 2019
Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemiaBrian Giacopelli, Qiuhong Zhao, Amy S Ruppert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2016
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung CancerVassiliki Papadimitrakopoulou, J Jack Lee, Ignacio I Wistuba, et al.
Blood|April 6, 2023
Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemiaQu Jiang, Johanna Stachelscheid, Johannes Bloehdorn, et al.
Cell Reports|December 30, 2015
MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199Juliana M Benito, Laura Godfrey, Kensuke Kojima, et al.
Pageof 34

Showing results (321-330 of 334) with videos related to

Sort By:
Pageof 34
Clinical Proteomics|September 13, 2011
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancerAna M Gonzalez-Angulo, Bryan T Hennessy, Funda Meric-Bernstam, et al.
Blood|April 16, 2010
microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survivalSimona Rossi, Masayoshi Shimizu, Elisa Barbarotto, et al.
Leukemia|January 24, 2014
BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignanciesJ M Bogenberger, S M Kornblau, W E Pierceall, et al.
Journal of the National Cancer Institute|January 17, 2012
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcomeNathan T Ihle, Lauren A Byers, Edward S Kim, et al.
Gynecologic Oncology|April 11, 2012
Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancerSiqing Fu, Bryan T Hennessy, Chaan S Ng, et al.
Cancer Discovery|September 11, 2012
Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1Lauren Averett Byers, Jing Wang, Monique B Nilsson, et al.
Blood|July 12, 2019
Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemiaBrian Giacopelli, Qiuhong Zhao, Amy S Ruppert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2016
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung CancerVassiliki Papadimitrakopoulou, J Jack Lee, Ignacio I Wistuba, et al.
Blood|April 6, 2023
Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemiaQu Jiang, Johanna Stachelscheid, Johannes Bloehdorn, et al.
Cell Reports|December 30, 2015
MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199Juliana M Benito, Laura Godfrey, Kensuke Kojima, et al.
Pageof 34